Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDIV × Cyclophosphamide × Clear all

Status

Sponsor Class

OTHER 186 NIH 87 INDUSTRY 19 OTHER_GOV 11 NETWORK 9 UNKNOWN 2 INDIV 1

Study Type

Observational 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

Tacrolimus 2 Pyridostigmine Bromide 2 Proflavine 2 Prednisone 2 plerixafor 1 olaparib 1 ethyl pyruvate 1 compound W 1 Uracil 1 Tegafur 1 Surgical Procedures, Operative 1 Steroids 1 Salicylates 1 PM 01183 1 Mycophenolic Acid 1 Methylprednisolone 1 Methotrexate 1 Immunosuppressive Agents 1 Immunoglobulins, Intravenous 1 Darbepoetin alfa 1 Cyclosporine 1 Cyclophosphamide 1 Curettage 1 Circumcision, Male 1 Azathioprine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡